Venkatesh Krishnan
Overview
Explore the profile of Venkatesh Krishnan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
4303
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simon N, Rudjito R, Moll L, Sandor K, Vazquez-Mora J, Kurtovic Z, et al.
Ann Rheum Dis
. 2025 Feb;
84(3):421-434.
PMID: 39924372
Objectives: Many rheumatoid arthritis (RA) patients continue to experience persistent pain even after successful management of joint inflammation. Clinical data indicate that RA patients treated with the JAK inhibitor baricitinib...
2.
Kuley R, Duvvuri B, Hasnain S, Dow E, Koch A, Higgs R, et al.
Arthritis Rheumatol
. 2024 Oct;
PMID: 39431356
Objective: Neutrophils play an important role in regulating immune and inflammatory responses in patients with rheumatoid arthritis (RA). We assessed whether baricitinib, a JAK1/JAK2 inhibitor, could reduce neutrophil activation and...
3.
De Vlam K, Maksymowych W, Gallo G, Rahman P, Mease P, Krishnan V, et al.
Rheumatol Ther
. 2024 Jun;
11(4):1063.
PMID: 38874859
No abstract available.
4.
Salani R, McCormack M, Kim Y, Ghamande S, Hall S, Lorusso D, et al.
Int J Gynecol Cancer
. 2024 Jun;
34(8):1140-1148.
PMID: 38858106
Objective: To evaluate tiragolumab (anti-TIGIT) and atezolizumab (anti-PD-L1) as second- or third-line therapy for PD-L1-positive persistent/recurrent cervical cancer. Methods: In the open-label, non-comparative, randomized phase II SKYSCRAPER-04 trial (NCT04300647), patients...
5.
De Vlam K, Maksymowych W, Gallo G, Rahman P, Mease P, Krishnan V, et al.
Rheumatol Ther
. 2024 Apr;
11(3):691-707.
PMID: 38637464
Introduction: The objective of this analysis is to evaluate the improvement in spinal pain with ixekizumab, placebo, and adalimumab based on objective measures of inflammation response in patients with ankylosing...
6.
Johnson T, Steere B, Zhang P, Zang Y, Higgs R, Milch C, et al.
Clin Transl Gastroenterol
. 2023 Aug;
14(11):e00630.
PMID: 37594044
Introduction: Mirikizumab, an anti-interleukin-23p19 monoclonal antibody, demonstrated efficacy in phase 2 and 3 randomized clinical trials of patients with moderate-to-severe ulcerative colitis (UC). Previous results have shown that 12 weeks...
7.
Ravichandran R, Amritanand R, Moses V, Kandagaddala M, Krishnan V, David K, et al.
Indian J Radiol Imaging
. 2023 Jun;
33(3):289-294.
PMID: 37362354
Infectious spondylodiscitis is a debilitating condition and evidence-based medicine dictates confirming the diagnosis before treatment. Computed tomography-guided spinal biopsy plays a major role and hence we would like to determine...
8.
Correa-de Araujo R, Evans W, Fielding R, Krishnan V, Carter R, Appleby J, et al.
J Gerontol A Biol Sci Med Sci
. 2023 Jun;
78(Suppl 1):94-100.
PMID: 37325963
Background: Functional limitations and physical disabilities associated with aging and chronic disease are major concerns for human societies and expeditious development of function-promoting therapies is a public health priority. Methods:...
9.
Bhasin S, Krishnan V, Storer T, Steiner M, Dobs A
J Gerontol A Biol Sci Med Sci
. 2023 Jun;
78(Suppl 1):25-31.
PMID: 37325955
Testosterone, many steroidal androgens, and nonsteroidal ligands that bind to androgen receptor and exert tissue-specific transcriptional activity (selective androgen receptor modulators [SARMs]) are being developed as function-promoting therapies to treat...
10.
Ochsner S, Pedroza M, Pillich R, Krishnan V, Konicek B, Dow E, et al.
J Invest Dermatol
. 2023 Mar;
143(9):1689-1699.
PMID: 36967086
Unbiased informatics approaches have the potential to generate insights into uncharacterized signaling pathways in human disease. In this study, we generated longitudinal transcriptomic profiles of plaque psoriasis lesions from patients...